2015 Feb 19
Fighting the War on Cancer
To really stand a chance against cancer, we should focus on more interdisciplinary collaboration, writes biomedical engineer Claudia Fischbach in this guest piece. Read more
2015 Feb 19
Communication networks discovered between tumors and surrounding microenvironment
A research team led by Vivek Mittal has identified complex communication networks between tumors and surrounding blood vessels, immune cells, connective tissue cells and structural cells. Read more
2015 Feb 18
Role of Transplantation in High-Risk CLL
Richard Furman, M.D., talks to OncLive about the role of allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia. Read more
2015 Feb 13
The Treatment Challenges of Neuroendocrine Prostate Cancer
Himisha Beltran, M.D., presented at the Chemotherapy Foundation Symposium about neuroendocrine prostate cancer, a high-risk, lethal subset of disease. Read more
2015 Feb 09
Mantle Cell Lymphoma Treatment Challenges
Associate professor Jia Ruan, M.D., Ph.D., talks to OncLive about initial treatment methods for mantle cell lymphoma (MCL). Read more
2015 Feb 09
Entrepreneurship in Action
Several Meyer Cancer Center members have been featured in the latest issue of Weill Cornell Medicine magazine. Read more
2015 Feb 07
Optimizing Treatment With Ibrutinib in High-Risk CLL
Richard Furman, M.D., director of Weill's CLL Research Center, participates in a panel discussion about therapy for patients with chronic lymphocytic leukemia (CLL) whose tumors harbor a 17p deletion. Read more
2015 Feb 05
Big Data and Bacteria: Mapping the New York Subway’s DNA
Pathologist Christopher Mason and his research team gathered DNA from turnstiles, ticket kiosks, railings and benches in a transit system shared by 5.5 million riders every day. Read more
2015 Feb 04
Onartuzumab for Gastroesophageal Adenocarcinoma
Manish A Shah, M.D., director of gastrointestinal oncology, discusses a recent phase II study of FOLFOX with or without onartuzumab, a MET inhibitor, for the treatment of metastatic gastroesophageal adenocarcinoma. Read more
2015 Feb 03
Researchers enthusiastic over Obama's new $215m precision medicine initiative
Mark Rubin, director of Weill Cornell's Institute for Precision Medicine, recently traveled to the White House as President Barack Obama unveiled a new $215m precision medicine initiative. Read more
2015 Feb 02
Advanced technology for more precise treatment of brain and spine tumors
Image-guided radiotherapy (IGRT) delivers highly accurate doses of radiation therapy to targeted areas in the brain while maximizing patient comfort in a procedure called stereotactic radiosurgery. Read more
2015 Jan 28
Leonard reflects on progress for lymphoma patients
John Leonard, M.D., associate director of clinical trials at the cancer center and director of Weill Cornell's Lymphoma Program, highlights advances in lymphoma research and clinical care. Read more
2015 Jan 22
The new style of tailored treatment
Irene Price is an early beneficiary of “precision medicine,” an approach that replaces the traditional one-size-fits-all cancer treatment paradigm with one that focuses on targeted, individualized care using a patient’s own genetic profile and medical history. Read more
2015 Jan 16
Drug study sheds light on gastroesophageal adenocarcinoma
Manish Shah, M.D., director of gastrointestinal oncology, talks about a recent phase II study of mFOLFOX paired with the MET inhibitor onartuzumab for the treatment of metastatic, HER2-negative gastroesophageal adenocarcinoma. Read more
2015 Jan 16
Furman discusses treatment options for patients with CLL
Richard Furman, director of Weill’s Chronic Lymphocytic Leukemia Research Center, weighs in on debates about when and how to treat patients with CLL. Read more
2015 Jan 15
Graduate student has cultured an unexpected side passion: Fish
In the course of trying to contribute to cures for cancer, Sara DiNapoli has cultured an unexpected side passion: Fish. Read more
2015 Jan 15
A new paradigm: Precision medicine
Cancer: It’s personal, and not only on an emotional level, but a molecular one. Every patient's cancer is unique, driven by distinct biological factors. So, too, should every patient’s treatment. Read more
2015 Jan 14
Meyer investigators land two of six prestigious national awards
Himisha Beltran and Christopher Barbieri were awarded Challenge Awards from the Prostate Cancer Foundation, two of only six distributed nationwide. Read more
2014 Dec 18
New understanding of macrophage gene regulation could help control cancer
A new database that maps how cells regulate gene expression could provide strategies to stop tumor growth. Read more
2014 Dec 15
Molecular link discovered between prostate and breast cancer, suggesting new treatment approach for men's tumor
Prostate cancer can be driven by the same estrogen receptor responsible for the most common form of breast cancer. Read more
